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ABBREVIATIONS
ANC Absolute neutrophil count
BMI Body mass index
CC Corpus callosum
CSF Cerebrospinal fluid
CFU-GM Granulocyte macrophage progenitors
D Diopter
EEG Electroencephalography
ECG Electrocardiography
FSH Follicle stimulating hormone
GNRH Gonadotropin releasing hormone
HM Hand movement
IGF-1 Insuline-like growth hormone
LH Luteinizing hormone
LP Light perception
MISS Mid internal scull surface
MRI Magnetic resonance image
RBC Red blood cell
RP Retinitis pigmentosa
RPE Retinal pigment epithelium
rhG-CSF Granulocyte colony stimulating factor
SDS Standard deviation score
TSH Thyroid-stimulating hormone
VA Visual acuity
WBC White blood cell count
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INTRODUCTION
In 1968 and 1972, Dr Michael Cohen from Canada observed two siblings
and a third patient, respectively, with a previously unrecognised pattern of
abnormalities. In 1973, he described these patients to have a new syndrome
(Cohen et  al, 1973). In the next report, Carey and Hall (1978) established
the Cohen syndrome to be a clinical entity by presenting four new patients
with similar findings.
In 1968  Reijo Norio and his colleagues began to follow three Finnish
patients having abnormalities that did not fit any known syndrome: mental
retardation, typical facies, slender hands and feet, and signs of chorioretinal
dystrophy.  In 1978, after taking a look at the patients described by Carey
and Hall (1978), Norio realised that their patients had Cohen syndrome.
Since then, a large number of Finnish patients with Cohen syndrome
have been found. As it seemed to be overrepresented in Finland, we had
an excellent opportunity to undertake a nationwide clinical study of the
Cohen syndrome.
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REVIEW OF LITERATURE
1. General aspects of the Cohen syndrome
The first published  Cohen syndrome patients had following features: mental retar-
dation, microcephaly, antimongoloid slant, mild maxillary hypoplasia, short philtrum,
open mouth with prominent maxillary central incisors, micrognathia, highly arched
narrow palate, crowded teeth, hypotonia, obesity, narrow hands and feet, tapering
extremities, cubitus valgus, genua valga, lumbar lordosis, mild thoracic scoliosis
and hyperextensibility of the joints (Cohen et al, 1973). In the next report, in which
the syndrome was already called Cohen syndrome, all 4 patients had hyperextensibili-
ty of the joints, narrow hands and feet, high nasal bridge and micrognathia. Further-
more, 3 out of 4 had a short philtrum and 2 out of 4 had down-slanted eyes (Carey
and Hall, 1978).
Subsequent to these first reports, there have been reports of over one hundred patients
suggested to have Cohen syndrome (MIM n:o 216550) in the literature (Balestrazzi et
al, 1980, Sack and Friedman, 1980, Fryns et  al, 1981, Kousseff 1981, de Toni and
Cafiero, 1982, Ferre et  al, 1982, Friedman and Sack, 1982, Goecke et  al, 1982,
Doyard and Mattei, 1984, Fuhrmann Rieger et  al, 1984, Norio et  al, 1984, North et
al, 1985, Wilson et  al, 1985, Resnick et  al, 1986, Sack and Friedman, 1986, Rizzo et
al, 1987, Young and Moore, 1987, Zeller et  al, 1987, Zetler et  al, 1987, Mehes et  al,
1988, Moreno-Montanes et  al, 1988, Nambu et  al, 1988, Fryns et  al, 1990, Kondo et
al, 1990, Kondo et  al, 1990, Warburg et  al, 1990, Fryns et  al, 1991, Martinez et  al,
1991, Massa et  al, 1991, Özturk and Weber, 1991, Steinlein et  al, 1991, Higgins et
al, 1994, Schlichtemeier et  al, 1994, North et  al, 1995, Fryns et  al, 1996, Okamoto
et  al, 1998).  As there is no test to confirm the diagnosis, these reports are based on
clinical findings.
In 1984 Norio et al. reported on 6 Finnish patients, all of whom had high-arched or
wave-shaped eyelids, long, thick eyelashes, thick eyebrows, prominent root of nose,
short philtrum, open-mouthed appearance, high and narrow palate, small or absent
lobuli of ears, thick hair and low hairline, narrow hands and feet, mild syndactylies
and a wide gap between toes I and II.  All these six patients also had chorioretinal
dystrophy and, as a previously unpublished feature, granulocytopenia.
Patients clinically similar to Cohen syndrome have also been published with other
names. In 1972 Mirhosseini et al. reported two brothers with pigmentary retinal dege-
nerations, cataracts, hyperextensible joints, microcephaly and severe mental re-
tardation. Thirteen years later Mendez published on two sisters having ”Mirhosseini-
Holmes-Walton syndrome”. All these four patients were clinically very similar to Cohen
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patients and in 1986 Norio and
Raitta suggested these two syn-
dromes are identical. In 1994 Part-
ington and Anderson described
three patients with developmental
delay, microcephaly, friendly per-
sonality, myopia and distinctive
facial appearance. Norio’s response
that these patients have Cohen
syndrome (Norio 1994) was sub-
sequently accepted (Partington
and Anderson, 1994).
Many of the reported patients have
been siblings and their parents
have been healthy. Thus, Cohen
syndrome is considered to be an
autosomal recessive disorder. In
Finland linkage studies were per-
formed with the assumption of au-
tosomal recessive inheritance and
the gene was mapped to the long
arm of chromosome 8 in 1994
(Tahvanainen et  al, 1994). The re-
fined mapping of the Cohen syn-
drome gene by linkage disequilib-
rium was reported, also in Finland,
in 1997 (Kolehmainen et  al, 1997).
The haplotype association showed
that out of  the 29 detected Cohen chromosomes 25 very probably represented one
mutation derived from one ancestor. Thus it seems that the Finnish Cohen patients
have one main mutation and possibly two other rare ones in the same locus. Very
probably, this main mutation, together with the isolated Finnish population structure,
caused the overrepresentation of this disorder in Finland.
Thus far 34 Cohen syndrome patients have been diagnosed in Finland. They come
from 26 families. The incidence of Cohen syndrome in Finland has been estimated to
be  1:105 000. The birthplaces of grandparents from 18 families are shown in Fig 1
(Norio, personal communication). Cohen syndrome in Finland is highly homogenous,
both clinically and molecular-genetically, whereas confusing heterogeneity exists in
the international literature among patients reported to have Cohen syndrome.
Figure 1. Birth places of grandparents of
18 Cohen families.
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Article Age(years)/
sex(F/M)
Imaging
method
Result
Fryns 1981 20/M CT Normal
Resnick1985 17/F CT Normal
Gabrielli 1989 11/? MRI A large cellar cavity compared with the size of the hypophysis,
which was reduced in thickness
Fryns 1990 15/F CT Normal
Ötzurk 1991 14 /F MRI A small round calcification near the right basal ganglion
Higgins 1994 4/F MRI Normal
Schlichtemeier 1994 13/ M CT A large left frontal haemorrhage and thrombosis of the superior
sagittal sinus
North
1995
8/F MRI A 2-3 mm lesion in the right cerebellopontine angle that was
hyperintense on T-1 and hypointense on T-2 weighted images
Fryns 1996 3/F
3/F
MRI
MRI
Normal
Normal
2. Studies of the central nervous system
Mental retardation, microcephaly, delayed developmental milestones and hypotonia
are common findings in Cohen patients. All three patients reported by Cohen and his
coworkers (1973) were mentally retarded. In the following report of four patients with
this syndrome, three were mentally retarded. One patient, an 11-year-old boy, was not
reported to be mentally retarded, but had poor social adjustment (Carey and Hall,
1978). All other patients were reported to be mentally retarded. The degree of mental
retardation has varied. Mild (IQ50-69) (Cohen et al, 1973, Balestrazzi et al, 1980,
Sack and Friedman, 1980, Friedman and Sack, 1982, Sack and Friedman, 1986, Young
and Moore, 1987, Warburg et al, 1990, Schlichtemeier et al, 1994, North et al, 1995),
moderate (IQ35-49) (Kousseff 1981, Goecke et al, 1982, Nambu et al, 1988, Fryns et
al, 1991), severe (IQ 20-34) and profound (IQ under 20) mental retardation (Cohen et
al, 1973, Carey and Hall, 1978, Fryns et al, 1981, Mehes et al, 1988, Fryns et al, 1990,
Kondo et al, 1990, Özturk and Weber, 1991, Fryns et al, 1996) have been noted. In
many reports Cohen patients have been found to have a ”cheerful disposition,” friend-
ly attitude, good nature or euphoric, interactive personality (Fryns et al, 1981, Kouss-
eff 1981, Norio et al, 1984, Sack and Friedman, 1986, Schlichtemeier et al, 1994,
North et al, 1995). Few patients have been mentioned to have autistic (Fryns et al,
1996) or aggressive (Young and Moore, 1987) features.
Previous reports on the morphology of the brain in  Cohen syndrome are scanty. No
histopathological studies are available.  Only few magnetic resonance imaging or com-
puted tomography studies have been published. Some of them have shown unspeci-
Table 1. Previous MRI and CT of the Cohen syndrome patients.
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fied changes (Gabrielli et  al, 1989, Özturk and Weber, 1991, Schlichtemeier et al,
1994, North et al, 1995) and other few reports have shown normal brain CT or MRI
(Fryns et al, 1981, Resnick et al, 1986, Fryns et al, 1990, Fryns et al, 1996) (Table1).
Neurophysiological studies are also rare. Cohen et al. (1973) found mild seizures and
diffuse synchronous high-voltage spike and wave discharges in one of his three pa-
tients. Goecke et al. (1982) reported one patient to have right-sided focus with hyper-
synhcronic potentials in EEG at the age of 11 years. Only few patients have been
reported to have epilepsy (Cohen et al, 1973, Goecke et al, 1982, North et al, 1985),
while others have been mentioned to be seizure-free. Normal electroencephalograms
(EEG) have been reported at all ages (Sack and Friedman, 1980, Fryns et al, 1981,
Resnick et al, 1986, Mehes et al, 1988, Warburg et al, 1990, Fryns et al, 1996).
3. Ophthalmologic studies
Cohen and his co-workers (1973) found myopia, mottled retina and prominent choroi-
dal vessels in two of the three patients. Furthermore two of his patients had strabismus
and one of them had microphthalmia and coloboma. Carey and Hall (1978) reported
one of their four patients aged 11 years to have mottled pigmentation bilaterally, but
did not report it to indicate any ophthalmologic abnormality. The first ones to concen-
trate on ophthalmologic features in Cohen syndrome in detail were Norio and his co-
workers (1984). Their six patients manifested the following ophthalmologic symp-
toms and findings; myopia in five, astigmatism in four, strabismus in three, optic
atrophy in five and chorioretinal dystrophy in all six. Visual acuity varied from 0.8 to
counting fingers at 2-5 meters in the older patients. The progression of visual impair-
ment was mentioned to be slow, and only the oldest patients were definitely visually
handicapped. Visual impairment was caused by chorioretinal dystrophy and patients
had symptoms related to it such as marked difficulties in seeing in dusk, and difficul-
ties related to constricted visual fields. Since then, other reports of these and other
ophthalmologic findings have been published: myopia, astigmatism, strabismus, mi-
crocornea, microphthalmia, sluggish pupillary reaction, pigmentary fundus changes,
optic atrophy, bull’s eye macula, coloboma, ptosis  and exopthalmos (Table 2). Pat-
terns of ophthalmologic changes have varied greatly and some findings like coloboma
may have been coincidental. There are, however, reports of patients claimed to have
Cohen syndrome without ophthalmologic abnormalities (Zeller et al, 1987, Nambu et
al, 1988) or only unspecific changes such as  exotropia (Balestrazzi et al, 1980, Kousseff
1981, Goecke et al, 1982, Zetler et al, 1987) or esotropia (Fryns et al, 1981, Mehes et
al, 1988). It has been discussed whether mottled retina justifies a distinction between
a Finnish and a Jewish type of Cohen syndrome (Kondo et al, 1990).
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4. Haematological studies
Norio et al. (1984) were the first to report leucopenia due to granulocytopenia in six of
their patients. It was mild and intermittent and did not seem to harm patients. One of
their patients had been hospitalised with neonatal diagnosis. Warburg et al. (1990)
reported a 27-year-old girl with leucopenia (observation period 1972 - 1985) ranging
from 1.9 to 3.9x109/l, and neutrophilic count ranging from 0.3 to 0.7x109/l. Differen-
tial counts showed lymphocytosis, but only few granulocytes (10 - 30%). This patient
had normal values of haemoglobin, RBC counts, thrombocytes, eosinophils, immu-
noglobulins A, G, and M; vitamin B12 and folic acid. The morphology of peripheral
blood cells was normal, but no bone marrow aspiration was done. Warburg classified
this patient’s neutrophilic granulocytopenia as chronic idiopathic neutropenia. A few
such patients have been noticed elsewhere (Kondo et al, 1990, Özturk and Weber,
1991, Steinlein et al, 1991). Fryns et al. (1996) found granulocytopenia to be present
from the beginning and to remain unchanged and not to be associated with higher
susceptibility to infections.
5. Other studies
Cardiac findings
Sack and Friedman (1980) reported a floppy mitral valve with mild regurgitation in a
12-year-old patient. The diagnosis was based on systolic heart murmur, ECG and
echocardiography. Mehes et al. (1988) found a mitral valve prolapse in a girl aged 2
years with Cohen syndrome. The methods for diagnosing mitral valve prolapse were
not discussed. In five of their six patients Norio et al (1984) found a grade 2 - 5
systolic murmur, which was found to diminish or disappear with advancing age. One
of the patients had transient myocardial insufficiency at the age of 4 months; others
had no cardiac symptoms.  Schlichtemeier et al. (1994) reported a 13-year-old male
with Cohen syndrome with normal cardiac anatomy but a dilated, tortuous descend-
ing aorta.
Endocrine function
Cohen et al. (1973) reported their patients to have midchildhood obesity. Carey and
Hall (1978) reported their four patients to have obesity and three to have delayed
puberty and short stature.  Norio et al. (1984) reported that their six patients had been
born at term or later, but birth weight was relatively low. Since then, many reports on
short stature (Carey and Hall, 1978, Kousseff 1981, de Toni and Cafiero, 1982, Goecke
et al, 1982, Resnick et al, 1986, Young and Moore, 1987, Zeller et al, 1987, Warburg
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et al, 1990, North et al, 1995), truncal obesity (Cohen et al, 1973, Carey and Hall,
1978, Balestrazzi et al, 1980, Sack and Friedman, 1980, Kousseff 1981, Ferre et al,
1982, Friedman and Sack, 1982, North et al, 1985, Zeller et al, 1987, Zetler et al,
1987, Nambu et al, 1988, Fryns et al, 1990, Warburg et al, 1990, Massa et al, 1991,
Steinlein et al, 1991, Fryns et al, 1996) and  delayed puberty (Balestrazzi et al, 1980,
Fryns et al, 1981, Kousseff 1981, Sack and Friedman, 1986, Kondo et al, 1990, War-
burg et al, 1990, North et al, 1995) have been published. Massa et al. (1991) reported
impaired growth hormone secretion in a 12-year-old girl with suspected Cohen syn-
drome and short stature. Carey and Hall (1978) reported normal GH secretion in one
of their four patients. Resnick et al. (1986) reported a 17-year-old female with low
normal growth hormone level and normal somatomedin level. In this patient the usual
increase in growth hormone secretion after exercise was blunted.
Nambu et al. (1988) reported a case of a 12-year-old girl with Cohen syndrome asso-
ciated with diabetes mellitus. Fuhrmann-Rieger et al. (1984) reported a 12-year-old
girl whose oral glucose test, as they say, ”demonstrated a diabetic type”.
Balestrazzi et al. (1980) reported delayed onset of puberty in two patients without LH
and FSH deficiency. Their LH and FSH values after LH-RH stimulation were normal.
Skeletal features
In the first report of this syndrome all three patients were hypotonic and had lumbar
lordosis and mild thoracic scoliosis (Cohen et al, 1973). Norio et al (1984) speculated
that the postural abnormalities of their 6 patients, viz. articular hypermobility, cubitus
valgus, genu valgum, pes planovalgus and scoliosis, might be consequences of the
hypotonia. No radiological examinations were performed. The hands and fingers were
reported to be long and slender. Sack and Friedman (1986) found kyphoscoliosis in 21
of their 39 Cohen patients. Many others have reported these structural features (Carey
and Hall, 1978, Fryns et al, 1981, Goecke et al, 1982, North et al, 1985, Özturk and
Weber, 1991). Kondo et al (1990) reported X-rays of hands and feet of a 15-year-old
male showing long narrow metacarpals and proximal phalanges.
Altogether, some of the reports of Cohen syndrome have been too inadequately de-
scribed in order to evaluate the justification of the diagnosis.  Additionally, different
diagnostic criteria have been used in reports. Thus, marked heterogeneity exists among
reported Cohen patients. This will be discussed more thoroughly in the discussion
section.
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AIMS OF THE PRESENT STUDY
The aims of this study were
- to re-evaluate previously diagnosed Cohen patients and find and examine new
patients in Finland
- to describe the clinical features and the natural history of Cohen syndrome
with special emphasis on neurological, ophthalmologic, haematological,
cardiac, endocrine and radiological characteristics of this disorder and
- to find the congruent diagnostic criteria for Cohen syndrome and to evaluate
the heterogeneity of the syndrome.
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PATIENTS
1. Collection of patients
Prior to the beginning of a systematic search for this study in January 1995, there were
21 patients with a definite diagnosis of Cohen syndrome at the files of the Department
of Medical Genetics in the Family Federation of Finland Väestöliitto. In all of them,
the diagnosis had been made or confirmed by Reijo Norio. The suspicion of Cohen
syndrome had usually arisen when a mentally retarded patient presented with typical
facial features: wave-shaped, often downslanting lid-openings, thick eyebrows and
eyelashes, short philtrum and the upper lip seemingly too short to cover the upper
teeth. Other very common features were microcephaly, hypotonia and a  sociable and
cheerful disposition. Also ophthalmologic features were required for the diagnosis, in
accordance with the presentation of Norio et al. (1984). There is no laboratory test to
confirm the diagnosis, nor is the gene known.
In order to find more patients, a nationwide search was undertaken by giving lectures
on Cohen syndrome for neuropediatricians, pediatricians, clinical geneticists, oph-
thalmologists and other medical personnel, who take care of mentally retarded pa-
tients. Additionally an information letter about this syndrome including patient pic-
tures was sent to neuropediatricians and to doctors for mentally retarded patients.
Special effort was directed to reaching the diagnosis already in infants. During the
years 1995 to 1997 many suspected cases were referred and after careful diagnostic
evaluation 8 new evident diagnoses of Cohen syndrome were made.
At the beginning, letters of invitation were sent to the 21 original patients. The fami-
lies were approached by their family doctors. With the permission of either parents or
guardians the detailed program for investigations was sent and the informed consent
was requested. Of those 21 original patients, 15 attended the study protocol in 1994-
1997 in the Hospital for Children and Adolescents, Departments of Child Neurology
and Pediatrics, and Departments of Radiology and Ophthalmology, Helsinki Univer-
sity Central Hospital, Finland. Clinical studies of two patients were totally refused by
parents or guardians, but hospital files were available. Four of the original patients
attended studies partly. Furthermore 3 new patients aged 11 months, 2 years and 39
years participated in whole protocol of the study and 5 new patient participated in
some parts of it. All available hospital files for 29 patients were reviewed. As some
parts of the study protocol turned out not to give important information of the syn-
drome, they were discontinued after the first consecutive patients. In Table 3 the par-
ticipation of the 29 patients in different parts of the study is shown. The patients were
numbered from  1 to 29 according to their present age.
13
Ta
bl
e 
3.
 
Pa
rti
ci
pa
tio
n 
of
 th
e 
29
 C
oh
en
 p
at
ie
nt
s i
n 
va
rio
us
 p
ar
ts 
of
  t
he
 st
ud
ie
s
N
:o
Se
x
Pa
rt
ic
ip
at
io
n
A
ge
 a
t t
he
tim
e 
o
f
in
ve
st
i-
ga
tio
ns
(ye
ars
)
H
os
pi
ta
l f
ile
s
Cl
in
ic
al
ev
al
u
at
io
n
M
R
I s
tu
di
es
EE
G
 
+
 
o
th
er
n
eu
ro
lo
gi
ca
l
st
u
di
es
Ps
yc
ho
lo
-
gi
ca
l s
tu
di
es
O
ph
th
al
m
o
-
lo
gi
c 
st
u
di
es
H
ae
m
at
o
lo
-
gi
ca
l s
tu
di
es
Ca
rd
ia
c
st
u
di
es
En
do
cr
in
e
st
u
di
es
O
th
er
ra
di
ol
o
gi
ca
l
st
u
di
es
1
M
1
+
+
+
+
+
-
-
+
+
+
2
F
2
+
+
-
-
-
-
-
-
-
-
3
M
2
+
+
+
+
+
+
-
+
+
-
4
M
5
+
+
-
-
-
-
-
-
-
-
5
F
5
+
+
+
+
+
+
+
+
+
+
6
F
6
+
+
-
-
-
-
-
-
-
-
7
M
14
+
+
+
+
+
+
+
+
+
+
8
F
15
+
+
+
+
+
+
+
+
+
+
9
F
19
+
+
-
-
-
+
+
-
-
-
10
F
20
+
+
+
+
+
+
+
+
+
+
11
M
21
+
+
-
-
-
+
-
-
-
-
12
M
20
+
+
+
+
+
+
+
+
+
+
13
F
23
+
-
-
-
-
-
-
-
-
-
14
F
26
+
+
+
+
+
+
+
+
+
+
15
M
27
+
+
+
+
+
+
+
+
+
+
16
F
30
+
-
-
-
-
-
-
-
-
-
17
M
32
+
+
+
+
+
+
+
+
+
+
18
M
34
+
+
+
+
+
+
+
+
+
+
19
M
34
+
+
+
+
+
+
+
+
+
+
20
F
39
+
+
+
+
+
+
+
+
+
+
21
F
39
+
+
+
+
+
+
+
+
+
+
22
F
40
+
+
-
-
-
+
-
-
-
-
23
F
42
+
+
-
-
-
+
-
+
-
+
24
M
44
+
+
+
+
+
+
+
+
+
+
25
F
45
+
+
+
+
+
+
+
+
+
+
26
F
46
+
+
-
-
-
+
-
+
-
+
27
F
51
+
+
+
+
+
+
+
+
+
+
28
M
57
+
+
+
+
+
+
+
+
+
+
29
F
58
+
-
-
-
-
-
+
-
-
-
To
ta
l
29
26
18
18
18
22
18
20
18
19
14
Six patients (numbers 10, 12, 14, 17, 19, 21) have been earlier published by Norio et
al. (1984). 21 patients (Numbers 1, 3, 5, 7-12, 14, 15, 17-21, 23-28) participated to the
study of refined mapping of the Cohen syndrome gene by linkage disequilibrium
(Kolehmainen et al, 1997).
2. Ethical aspects
Some of the tests that we conducted caused moderate pain or demanded good co-
operation. Thus general anaesthesia was required in some cases, though never more
than once for a patient. Some investigations included a small, but not fully negligible
risk of complications. The patients were mentally retarded and thus could not give
their informed consent.  However, it would not have been possible to obtain information
about Cohen syndrome by any other means than through an examination of a series of
patients. The results of the study will probably benefit both these patients themselves
and future Cohen patients. Thus, these procedures were considered ethically justified
by our study group and also by the ethical committees of the University of Helsinki:
Hospital for Children and Adolescents, the Department of Radiology, Department of
Ophthalmology, and by the Ethics Committee of the Family Federation of Finland
Väestöliitto, Helsinki.
Permission for studying the hospital records of diagnosed and suspected Cohen
patients was granted by the Finnish Ministry of Social Affairs and Health.
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METHODS
1. General clinical evaluation  (II, V and unpublished data)
Patients available for the studies were invited to the Hospital for Children and Adoles-
cents, Helsinki University, Finland. The scheduled investigations took one week per
patient. A history was obtained from the patients’ parents or their nursing staff, and
current status was determined for 26 patients (all but patients number 13, 16, 29). All
available previous hospital files of all 29 patients were collected.
History included clinical neuropediatric features of family history, pregnancy, deliv-
ery, neonatal period and childhood development: social, motor, fine motor and lan-
guage development according to normal standards, history of visual capacity and hear-
ing problems. Status investigation included standard somatic and detailed neurologi-
cal status. The table of manifestations published by Norio et al. (1984) was filled
individually in detail.
2. Examinations of the central nervous system (I and II)
MR imaging (I)
A) Midline internal skull surface
(MISS)
B) Surface of corpus callosum
Sagittal diameters of
     1. genu of CC
     2. body of CC
     3. splenium of CC
     4. mesencephalon
     5. pons
     6. medulla oblongata
Figure 2.
A sagittal image (T-1-weighted) showing the places of measurements.
16
Altogether, 17 consecutively seen patients (3, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 24, 25,
27, 28) underwent 1.0 Tesla and one patient 1.5 Tesla brain MRI (1). The MRI method
is described in detail in article I. To serve as controls, 27 age- and sex-matched healthy
volunteers were recruited. Six of the Cohen patients were imaged under anaesthesia.
The control persons received no medication. On the MR images of 15 patients and 27
age- and sex-matched controls, surface area of the corpus callosum (CC), sagittal
diameter of the genu, body and splenium of CC, midline internal skull surface (MISS),
sagittal diameters of the mesencephalon, pons, and medulla oblongata and signal in-
tensities at many sites in the white matter and grey matter were measured as described
in article I (Fig.2). Differences between patients and controls were tested with the
Mann-Whitney U-test.
EEG  (II)
Quantitative EEG was performed on 18 patients (1, 3, 5, 7, 8, 10, 12, 14, 15, 17 - 21,
24, 25, 27, 28 in table 4) as described in article II.
Psychological tests (II)
The degree of mental retardation was tested for 15 adult patients by using the WPPSI-
R test (7, 8, 10, 12, 14, 15, 17 - 21, 24, 25, 27, 28) (Wechsler 1967) and for 3 child
patients (patients 1, 3 and 5; aged 11 months to 5 years) using Bailey test for IQ
scoring (Bailey 1969). In order to evaluate patients’ behavioural profile the adaptive
behaviour scale for children and adults (AAMD) (Nihira et  al, 1975) for 15 patients
(7, 8, 10, 12, 14, 15, 17 - 21, 24, 25, 27, 28; aged 14 years to 57 years) was performed.
The tests are described in article II.
Other neurological evaluations  (II)
Cerebrospinal fluid was aspirated from 10 patients (5, 8, 10, 14, 15, 17 - 19, 21, 24).
Muscle biopsy (M. vastus lateralis) was obtained from 5 patients (8, 14, 17, 19 and
21). Serum concentrations of creatinine kinase (CK), lactate, pyruvate as well as blood
pH were evaluated from 18 patients (1, 3, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 24, 25, 27,
28). Also EMG was performed on these 18 patients. Motor and sensory nerve conduc-
tion velocities were measured both from the upper and lower extremities.
3. Ophthalmologic examinations (III)
Altogether, 22 patients (3, 5, 7 - 12, 14, 15, 17 - 28) participated in ophthalmologic
examinations. Detailed histories of visual performance and symptoms of nyctalopia
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and constricted visual fields were recorded. The ability to perform tasks needing sight
was registered. The use of sight was also evaluated by observing the patient for sever-
al days (SK-K). The use of sight both for near and distance was graded as shown in
Table 4.
Detailed ophthalmologic examination included cycloplegic refraction, measurement
of visual acuity (VA) both for near and distance viewing, examination of the ocular
adnexa and the anterior segment, especially lens and iris.  Fundus changes were exam-
ined as described in detail in article III.
To the four  first consecutively seen  patients flash evoked electroretinography (ERG)
and flash visual evoked potentials (VEP) were registered. ERG was not registered in
further patients with typical advanced fundus changes or when it was known to be
isoelectric in an earlier investigation. ERG was also performed to the two youngest
patients.
Retrospective data collection
The charts of 14 patients (8, 10, 12, 14, 15, 17, 19, 21, 23 - 28) with available previous
ophthalmologic examinations performed at the Department of Ophthalmology, Uni-
versity of Helsinki were reviewed as described in article III.
Statistical methods
Computations were performed using the BMDP software (Corkland, Ireland). Data of
refraction were expressed in spherical equivalent (SE). The quantitative variables (age,
follow-up and cyclorefraction) were presented as median and range. The data on the eye
with the better VA or on the one without constant deviation were chosen to represent a
patient. In case of equal VA and ortophoria, the values for the right eye were used.
Table 4. The use of sight.
 Grade 1  No problems encountered in near or distance vision
 
 Grade 2  Some difficulties in distance vision, but detailed close work done without
difficulties in daily practice, such as work or a hobby, e.g. embroidery
 
 Grade 3  Difficulties in distance vision, but can watch cartoons and/or look at comics
 
 Grade 4  Difficulties in distance and near vision, but still able to move around in
familiar places
 
 Grade 5  Hardly no use of sight for near or distance, only techniques for blind used
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4. Haematological examinations (IV)
The hospital files of 29 patients were reviewed, including data of all the haematolo-
gical tests done, infections, other disorders and medications. Granulocytopenia was
defined as an absolute neutrophil count  (ANC) of  < 1.0 x 109/l in infants, <1.5 x 109/
l in other children and <1.8 x109/l in adults (Lanzkowsky 1989). Haematological stud-
ies were performed on sixteen consecutive Cohen patients (5, 7,  8, 10, 12, 14, 15, 17
- 21, 24, 25, 27 and 28). Haemoglobin, red blood cell indices, WBC and platelet
counts were determined with Coulter counter. Reticulocytes and WBC differential
were counted microscopically. Bone marrow was aspirated in 12 patients (7, 10, 12,
14, 15, 17 - 21, 24, 28) and biopsied in 3 from iliac crest (20, 24, 28). Previous bone
marrow aspirates were available from 2 (8, 25) and a biopsy from 1 (8) of the 16
patients. In addition to the 16 patients, aspirates from 2 more female patients ( 9 and
29) aged 19 and 58 years were reinvestigated. The marrow samples were evaluated for
cytology (n=16) and for morphology (n=4). The numbers of marrow myeloid cells in
the aspirate smears were counted in 16 patients and compared to those in 16 age- and
sex-matched healthy donors for bone marrow transplantation. Differences between
the groups were tested with a nonparametric Mann-Whitney U-test.
Granulocyte macrophage progenitors (CFU-GM) of bone marrow were cultured (Jan-
tunen et  al, 1996). Normal bone marrow donors served as controls (n= 45).
Cytogenetic analysis was done in 16 patients from peripheral blood and in 4 patients
from marrow. Granulocyte kinetics was studied by injecting adrenaline intramuscularly
into 14 patients and 3 healthy adult controls to estimate the granulocyte pool of the
peripheral blood, and on the next day hydrocortisone to 16 patients and 3 controls to
mobilise granulocytes of the bone marrow. Three patients were given a granulocyte
colony stimulating factor (rhG-CSF, filgastrin, Neupogen ®) 3 µg/kg subcutaneously
daily for three days. The methods used for the haematological studies are described in
detail in article IV.
5. Other evaluations (V)
Cardiac evaluation
All available histories of cardiac function was collected for all 29 patients. Twenty
patients ( 1, 3, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 23 - 28)  were examined by a pediatric
cardiologist. The evaluation included  cardiac auscultation,  X-ray,  ECG,  ultrasound
(Acuson 128; 3-5 MHz) and echocardiography as described in detail in article V.
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Evaluation of endocrine function
Height, weight and pubertal development were assessed in 22 (1, 3, 5, 7 - 12, 14, 15,
17 - 21, 23 - 28) of the patients. Weight was assessed relative to (%) mean weight in
the Finnish growth charts, and by body mass index (BMI= weight (kg)/height (cm)2)
in the adult patients. The history of pubertal development, menstruation and sexual
activity of all the 22 patients was ascertained by interviewing the parents or guardians.
Basal plasma levels of free thyroxin, thyroid stimulating hormone (TSH), insulin-like
growth factor (IGF-1), the gonadotropins, estradiol, testosterone, and concentrations
of potassium, sodium and glucose and blood glycohemoglobin were evaluated in 18
of the patients (1, 3, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 24, 25, 27, 28). Anterior pituitary
and adrenocortical functions were assessed with the insulin-arginine-ACTH test for
five patients (8, 14, 17, 19 and 21). For the methods see article V.
Evaluation of skeletal features (V)
X-rays of the chest, supine lumbar and thoracic spine, spine in the standing position
and long bones were taken from 17 (1, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 24, 25, 27, 28)
patients and hand X-rays from 19 patients (1, 5, 7, 8, 10, 12, 14, 15, 17 - 21, 23 - 28).
The ankles were radiographed in the standing position to evaluate the degree of valgus
deviation.
Both relative slenderness of the hand (minimal lengths of the metacarpophalangeal
and proximal phalangeal bones 2 and 4 divided by the thinnest diameter of the same
bones) (Parish 1966) and metacarpophalangeal pattern profiles (Poznanski et  al, 1972)
compared to healthy Finnish persons were defined from hand X-rays.
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Growth and development +/n %
Low birth weight (under 3kg) 13/21 62 %
Short stature (under –2 SD) 12/29 41 %
Obesity 5/29 17 %
Delayed puberty 10/13 77 %
Reduced fetal activity 9/18 50 %
Neonatal feeding difficulties 15/20 75 %
Psychomotor retardation 29/29 100 %
Microcephaly (under –2 SD) 29/29 100 %
Hypotonia 29/29 100 %
Hypermobility of joints 29/29 100 %
Cubitus valgus 7/23 30 %
Genu valgum 19/25 76 %
Pes planovalgus 25/28 89 %
Kyphosis (angle more than 40° or clinically
evident)
20/29 69 %
Scoliosis (angle more than 10°) 9/23 39 %
Motor clumsiness 29/29 100 %
Craniofacial manifestations
Antimongoloid slant of eyelids 13/29 45 %
High-arched or wave-shaped eyelids 29/29 100 %
Long/thick eyelashes 28/29 97 %
Thick eyebrows 25/29 86 %
Prominent root of nose 27/29 93 %
Short philtrum 29/29 100 %
Prominent upper central incisors 21/26 81 %
High/narrow palate 21/26 81 %
Small or absent lobuli of ears 15/27 56 %
Thick hair 29/29 100 %
Low hairline 29/29 100 %
Miscellaneous
Narrow hands and feet 28/29 97 %
Mild syndactylies 12/29 41 %
Wide gap between toes I and II 23/28 82 %
Brisk tendon reflexes 22/28 79 %
Cardiac systolic murmur 7/29 24 %
Granulocytopenia 29/29 100 %
High-pitched voice 19/28 68 %
Cheerful disposition 29/29 100 %
RESULTS AND DISCUSSION
1. General clinical manifestations
Clinical manifestations of the 29 patients are listed in Table 5.
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Development
Half of the mothers available for interviewing (n=18) remembered reduced fetal ac-
tivity during an otherwise normal pregnancy. As newborns the babies had usually
been considered normal, though they were often smaller than other children in their
families. Thirteen out of 21 patients (62 %) with available data of birth weight were
under 3 kilograms. Head circumferences at birth were within normal limits. 75 % of
patients had had neonatal feeding difficulties.
All patients had psychomotor retardation, which appeared not to be progressive. De-
velopmental delay was noted between 6 to 12 months of age. All developmental mile-
stones were delayed and children became microcephalic. All except one had had good,
sociable contact with other people from a very early age. Contact smiles had appeared
between 6 weeks to 3 months. Twelve out of 13 had been reported to be hypotonic or
floppy already during the first months of their lives.  By the age of one year all pa-
tients were hypotonic. The infants had been able to turn from prone to supine between
4 months to one year of age, to sit without support at the age of 10 months to 1.5 years
and to walk independently by the age of 2 to 5 years. Despite the symptoms of hypo-
tonia they showed early in life, at least four patients later developed spasticity in their
lower extremities. None had ataxia, but all had motor clumsiness. Tendon reflexes
were brisk in 79 %. None of the neurological symptoms were progressive. Other parts
of routine neurological status were non-contributory. All the patients learned to speak,
but the level of speech competence varied considerably, even among siblings. The
delay in speech development was often the most prominent feature about the child’s
developmental delay. They uttered their first word at 1 to 5 years of age and most but
not all could utter sentences at 5 to 6 years of age. However, most patients understood
speech better than they could speak themselves. All of our youngest patients received
speech therapy and used sign language successfully.
Craniofacial features
One of the inclusion criteries was ”typical facial features”, and so all patients had
these. When these features were analysed in detail, all patients had high-arched or
wave-shaped eyelids, short philtrum, thick hair, and low hairline. Additionally,  97 %
had long or thick eyelashes, 93 % had prominent root of nose, 86 % had thick eye-
brows, 81 % had prominent upper central incisors, 81 % had high or narrow palate, 56 %
had small or absent ear lobuli and 45 % had antimongoloid slant of eyelids. Also
notions about open-mouth appearance, maxillary hypoplasia, micrognathia and de-
fective folding of earlobes were presented in hospital files. However, the latter fea-
tures were not re-evaluated, because they are difficult to estimate with any accuracy
without taking specific measurements.
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Miscellaneous features
Ninety-seven percent had narrow hands and feet (judged by inspection, no measure-
ments), 41 % had mild syndactylies, 82 % had a wide gap between toes I and II, 68 %
had a high-pitched voice. All had granulocytopenia and 24 % had cardiac systolic
murmur. These features will be discussed in detail later.
Cohen syndrome should be suspected in children who are born at term and healthy,
but who by the age of 6 months to one year show hypotonia, microcephalia, delayed
developmental milestones,  and later delayed speech and non-progressive psychomo-
tor retardation, in addition to typical facial features.
2. Examinations of the central nervous system
MRI studies (I)
No focal signal intensity alterations in the brain were detected. The relation between
the grey and white matters in all subjects was normal. No significant changes existed
in the sizes of the CSF spaces; cerebral ventricles and sulci were not enlarged. How-
ever, some patients had wide CSF spaces around the pons. The corpus callosum gave
the impression of being large in comparison to other brain structures (Fig. 3). This
was the reason for measuring the corpus callosum (CC) as accurately as possible.
The surface area of the CC (Fig. 2) did not differ between patients and controls (p=0.2).
Diameters of the genu and the body of the CC were larger in the Cohen patients than
Figure 3. Sagittal image (T-1-weighted) of a 34-year-old Cohen male patient (left)
and a control person. Note thick corpus callosum in the patient.
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in the controls (p=0.06 and p=0.02, respectively). The diameter of the splenium did
not differ markedly (p=0.67). The MISS was significantly smaller in the patients
(p<0.0001). Sagittal diameters of mesencephalon (p<0.0001), pons (p<0.0001), and
medulla oblongata (<0.0001) were smaller in the Cohen patients than in the controls.
The signal intensities of the grey and white matter of the patients did not differ from
those of the controls. The surface area of CC/MISS ratio (%) was significantly higher
in the Cohen patients than in the controls (p<0.0001).
Relatively enlarged CC has not previously been reported in MRIs of Cohen patients
(Özturk and Weber, 1991, Fryns et al, 1996). However, no measurements were per-
formed. It would be interesting to re-evaluate those images.
It turned out to be difficult to speculate on the significance of the relatively enlarged
corpus callosum. Corpus callosum is composed of commissural fibers crossing from
one cerebral hemisphere to the other. It develops between the 12th and 22nd weeks of
gestation, and the formation proceeds from front to back. It is the main structure sub-
serving hemispheric collaboration. The size of the corpus callosum has been widely
studied both in healthy persons and in various patient groups. In 1991 Allen and Gor-
sky published a study of 122 age-matched adults for possible sex differences in the
corpus callosum. They found that the posterior region of the corpus callosum was
more bulbous in females and more tubular in males. They speculated whether these
anatomical sex differences could underlie the gender-related differences in behaviour
and neuropsychological function.
Agenesia or hypoplasia of the corpus callosum is one of the most common develop-
mental anomalies of the brain. Occasionally such hypoplasia or agenesia is found
incidentally in asymptomatic cases, while the common association is mental retarda-
tion. In contrast, a relatively large corpus callosum has not previously been reported to
be associated with mental retardation. Obviously, the form, growth, size and function
of the corpus callosum have been widely studied, but are still poorly understood (Kertesz
et  al, 1987, Allen and Gorski, 1991, Allen et  al, 1991, Weis et  al, 1993, Iai et  al,
1994, Egaas et  al, 1995, Woodruff et  al, 1995).
It might be speculated that if an enlargement of CC results in more axons and thus
more connections, a correlation may exist between an enlarged corpus callosum  and
the especially sociable attitude in Cohen syndrome. However, an enlargement of CC
may also reflect its abnormal structure and in addition, poorer connections.
A typical psychic disposition is also a feature in some other genetic retardation syn-
dromes. In the Williams syndrome the specific neurobehavioral profile has been sug-
gested to be associated with neocerebellar hemispheric preservation (Wang et  al,
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1992). However, practically nothing is known about the clinical-anatomical correla-
tion of phenomena of this kind.
This study confirmed that Cohen syndrome does not belong to the groups of disorders
of dorsal or ventral induction, proliferation, migration or myelinisation, all of which
can only be detected by MRI or CT.  MRI is valuable in diagnosis and differential
diagnosis. Though MRI alone can not confirm the diagnosis and no definite measure-
ments can be recommended for clinical use, any clinical suspicion of the Cohen syn-
drome will be reinforced, if the MRI shows a relatively enlarged corpus callosum in a
microcephalic head and normal signal intensities of grey and white matter.
EEG studies (II)
None of the patients had had seizures nor medication for epilepsy. The three youngest
patients had normal EEGs. All the others had low-voltage EEGs (Fig 4). No irritative
spikes or epileptiformic foci were found. Nine patients had quick beta transients (Fig
4).
The meaning of the low-voltage EEG was difficult to explain. Individuals with low-
voltage EEG usually have normal CNS functioning. Low-voltage tracings may also
reflect such abnormalities as vertebrobasilar artery insufficiency, pontine ischemia or
early pontine myelinolysis. Low-voltage EEG has been found in 1% of healthy per-
sons between the ages of 0 - 20 years, in 7% of those between 20 - 39 years and in 11%
Figure 4.
Low-voltage EEG with beta-transients in a 40-year-old female Cohen patient.
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of those between age 40 - 69 years. The prevalence of low-voltage tracings increases
sharply after the age of 13 years and, if found in a patient under 10 years old, suggests
that some abnormality is present (Niedermeyer et  al, 1982).
Patients with Usher syndrome (dystrophia retinae pigmentosa dysacusis syndrome)
have been reported to have flat EEGs (Nuutila 1968). In a series of 50 patients a flat
EEG was found in 36%. As the proportion of flat recordings increased after the patient
had become blind, it was thought to be a phenomenon accompanying sensory depri-
vation. However, Cohen patients with flat EEGs were not blind, though most were
severely visually handicapped.
The EEGs of nine patients showed fast beta activities. A beta activity of 30 - 40 Hz has
been reported to be more common in retarded individuals and those with psychiatric
disorders, but this association may be non-specific, as some normal individuals also
may have fast betas (Drake 1984).
Psychological tests (II)
All patients were mentally retarded, as it was an obligatory inclusion criteria.  Of 18
tested patients, four were profoundly, 11 severely, one moderately and two mildly
retarded.
The results of the AAMD scale are summarised in figures 5a and b. In part 1, which
evaluates skills important for the development of personal independence, Cohen pa-
tients had high scores (6 - 8) in self-direction, responsibility and socialisation. In part
two they had low scores (1 - 3), which reflects their almost total lack of maladaptive
behaviour. However, inappropriate interpersonal manners, stereotyped behaviour and
odd mannerisms were not uncommon (Fig.5). Withdrawal, sexually aberrant behav-
iour, untrustworthy and rebellious behaviour as well as antisocial behaviour were very
rare in Cohen persons.
The IQ of Cohen patients as assessed in our study was as low or lower than previously
reported. Of our patients 83% were classified as severely or profoundly retarded ac-
cording to the WPPSI-R and Bailey’s test. Obviously the virtual absence of maladap-
tive behaviour and high scores in socialisation and responsibility gave an impression
of a higher level of intelligence than the patients actually have. In many reports the
patients are described as cheerful and sociable which may be a reflection of these
dimensions.
Fryns et al. (1996) reported autistic behaviour with severe psychomotor retardation in
four Cohen children. Only one of our patients was known to have had autistic behav-
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iour during early infancy, but became sociable after the age of 3 years. The others
showed good sociable contact from an early age. However, relatively common do-
mains of maladaptive behaviour in Cohen persons were stereotyped behaviour and
odd mannerisms, which can also be interpreted as signs of autism.
Other neurological evaluations (II)
The five muscle biopsies showed no abnormalities. The motor and sensory nerve con-
duction velocities from the upper and lower extremities were all normal in 18 patients’
EMGs. Serum concentrations of CK, lactate and pyruvate as well as blood pH were
within normal limits.  The CSF tests showed that the patients’ proteins concentrations
were elevated (over 450 mg/L) in 8/10 patients (455-813mg/L). The reason for this is
not known. Their CSF-lactate and glucose concentrations were normal.
3. Ophthalmologic investigations (III)
Myopia and signs of retinochoroidal dystrophy were noticed in all patients over the
age of 5 years.  The results of investigations of visual function, refraction, strabismus,
adnexa and anterior segment of the eyes, lens changes and fundus changes are report-
ed in the following.
Visual function
At the time of the cross-sectional examination of 22 patients, only the two youngest
patients  (3 and 5, aged 2 and 5 years), had no ophthalmologic symptoms. All others
had some visual problems such as nyctalopia, constricted visual fields or impaired
vision. Nyctalopia always appeared before the age of 10 years, usually already at the
age of five. Symptoms of constricted visual fields, such as not seeing objects on the
floor when walking, appeared in the second decade of life and were evident in all
patients aged 20 years or over. 
Visual acuity worsened gradually (Fig. 6). Between the ages of 20 and 30 years, VA
remained unchanged (VA 0.5-0.1) in most patients and day-time visual function was
relatively good (Table 6). Central vision may remain good, while most of the periph-
eral field is lost. Twelve out of 20 patients aged 14 years or more were able to do close
work such as embroidery or looking at comics. Marked deterioration of vision to HM-
LP occurred sometimes before the age of twenty years or between the age of 30 to 40,
and inevitably by 50 years of age. Nobody was totally blind, confirming the observa-
tions of Norio et al. (1984).
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Refraction
Upon cross-sectional examination all 22 patients, excluding a 5-year-old girl, were
myopic. The median spherical equivalent (SE) of the present cycloplegic refraction in
the 19 patients with a median age of 27 years (range 2-46) was –11.0 D, ranging from
+1.0 to –19.75 D (Table 6). All but three had high myopia (>6 D) in one or both eyes,
and all but one had astigmatism. As judged from the longitudinal data, myopia was
progressive (Fig.7). With the exception of one patient, all had myopia already at the
time of the first measurement of cycloplegic refraction. On average, myopia had pro-
gressed –6.5 D (range –1.0 to –12.25D) during the follow-up period.
Figure 6.
Progressive reduction of visual acuity in
9 Cohen syndrome patients. The median
follow-up was 13 years (range 8 to 21
years). Visual acuity,  log MAR = loga-
rithm of the minimum angle of resolu-
tion. A visual acuity of 1.0 yields a log
MAR value 0, 0.5 = –0.3, 0.1 = –1.0, 0.05
= –1.5, hand movement = –2.0 and light
perception = –2.5.
Figure 7.
Progression in myopia in 9 Cohen syn-
drome patients. The median follow-up
was 15 years (range 8-32 years).
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In this series, all patients aged 14 years or more were myopic and the majority had
high myopia, similar to other reports (Özturk and Weber, 1991, Fryns et al, 1996).
Patients enjoyed wearing glasses, and correction of myopia and astigmatism affected
child’s development positively. The youngest Cohen syndrome patients reported to
have myopia were between one (Fryns et al, 1996) and three years (Balestrazzi et al,
1980, Fryns et al, 1996) of age, similar to our youngest patients.
We found progression in myopia, a new observation in contrast to some other studies
(Resnick et al, 1986, Kondo et al, 1990, Fryns et al, 1996). However, their follow-up
times were shorter (3 and 6 years) compared to our median follow-up of 15 years
(range 8 to 32 years).
Strabismus 
At the cross-sectional examination, patients under the age of 15 years had no strabis-
mus (Table 6), but a 5-year-old girl had been operated on for alternating esotropia at
the age of three. Of the older patients, two had ortophoria, two exophoria and 15
exotropia, non-alternating being more common than alternating. No cranial nerve pal-
sies were found.
Adnexa and anterior segment
All patients had typical wave-shaped, sometimes downslanting eyelids as well as thick
eyebrows and eyelashes. Eleven patients had mild lid changes, viz. buffy lids and
ptosis in younger patients and dermatochalasis and ptosis in older patients.
Two patients had corneal changes probably unrelated to Cohen syndrome; in one bi-
lateral nebulae in the lower part of the cornea, and in the other, bilateral temporal
band-shaped keratopathy. One female patient had had a bilateral acute angle closure
attack at the age of 42 years and peripheral iridectomies had been performed. Glauco-
ma is not infrequent in different forms of retinitis pigmentosa (RP). In general, pa-
tients with acute angle closure glaucoma are usually elderly and hyperopic. Our pa-
tient was myopic (-8.5D), however, her myopia was not axial, but caused rather by
increased corneal and lenticular power (unpublished data).
 
At the cross-sectional examination,  the intraocular pressure was normal in all 10
patients who allowed measurements to be made. Abnormal pupillary responses, miot-
ic pupils or sluggish pupillary reactions were seen in 16 patients, 9 of whom had iris
atrophy (Table 6).
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Lens changes
Lens opacities were seen in 13 patients in biomicroscopy; small cortical opacities
already in a 15-year-old female, and  early nuclear sclerosis in young adults. All pa-
tients over 40 years of age had nuclear sclerosis and spicular cortical opacities with or
without posterior subcapsular cataracts (Table 6). Lens opacitometry values, which
best measure the density of the nucleus, confirmed the presence of early nuclear scle-
rosis (Fig.8).
There was no mention of lens opacities in previous reports of Cohen syndrome. How-
ever, in the first report of Mirhosseini-Holmes-Walton syndrome (MIM n:o 26805)
(Mirhosseini et al, 1972) two patients, aged 28 and 24, had cataracts. Norio and Raitta
(1986) proposed that this syndrome and Cohen syndrome may be identical. Present
findings of early lens changes support this hypothesis also in respect to cataract for-
mation. Cataract is the most frequent anterior segment complication seen in RP (Weleber
1997). Cataract formation, especially central posterior subcapsular opacities, add to
the visual deterioration caused by advanced retinochoroidal dystrophy. Unfortunately,
cataract surgery performed to two patients (aged 34 and 52 years) did not improve
visual function due to advanced fundus changes (unpublished data).
Figure 8.
Values of lens opacitometry in 16 Cohen syndrome patients as a function of age. Dot-
ted lines indicate the normal range. Regression line indicates increasing density of
lens opacity with advancing age.
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Fundus changes
Upon cross-sectional examination, all had some signs of retinochoroidal dystrophy, ex-
cept  the youngest patient. His fundus was pale, which may be a normal finding for a
light-haired Finnish child. In others, the optic disk appeared pale and atrophic and the
vessels, especially arterioles, were narrowed already by the age of 10 years (Fig. 9B-D).
In most patients, the fundus was pale and the choroidal vessels were prominent because
of a thin retinal pigment epithelium (Fig. 9B-D, 10B). In seven patients, the fundus
appeared dark, in one due to normal appearing pigment epithelium (Fig. 9A), and in 6
due to heavily pigmented choroid. Some fine pigment granules and small pigment clumps
were seen in the youngest patients outside the posterior pole (Fig. 9A-C). In teenagers
and young adults, pigment clumps and even bone-spiculae-like pigmentations were
present (Fig. 10 B). Pigmentary changes increased in number during the follow-up peri-
od and approached the posterior pole (Fig 10D, 11B), appearing in oldest patients inside
the temporal arcades (Fig.11D, 12A,B). Widespread diffuse retinochoroidal atrophy was
seen in all but the youngest patients (Fig.10B, 11 B,D, 12 A,B). Many patients had
marked peripapillary atrophy (Fig.9 D), sometimes in a lacunar shape (Fig.10D). The
macular area was best preserved and in many patients, a central island of thicker retina
and normal-looking retinal pigment epithelium was seen (Fig. 9B, 10B). This area di-
minished in size during the follow-up period (Fig. 10D). The so-called bull’s eye macula
was seen in most patients (Fig. 9B-D, 10 B,D, 12A,B). In older patients, distinct areolar
retinochoroidal atrophy approached the posterior pole with pigmentary changes, leav-
ing a stellated pigmented area in the center of the macula (Fig.11D, 12A,B).
Fundus abnormalities in Cohen syndrome resemble those seen in retinitis pigmentosa
(RP), thus the former should be classified as one of the syndromes associated with RP.
Typical fundus changes of RP were seen in all but the youngest patients. Cohen et al.
(1973) described mottling of the retinal pigment epithelium, which most probably refers
to similar changes as seen in our patients. Carey and Hall (1978) reported one of their
four patients, aged 11 years, to have mottled pigmentation. In the following reports, the
fundus has either been normal (Balestrazzi et al, 1980, Fryns et al, 1981, Kousseff 1981,
Goecke et al, 1982, Doyard and Mattei, 1983, Wilson et al, 1985) or the macula had
mottled pigmentation (Sack and Friedman, 1980, Friedman and Sack, 1982). The oph-
thalmologic findings of some of these patients may have been imprecisely described,
maybe as a  consequence of the difficulty in investigating mentally retarded patients
thoroughly due to poor co-operation. Thus it is important to determine whether oph-
thalmologic findings are truly absent or if they could have been found with more
meticulous investigations.
The first to describe typical  fundus changes in detail were Norio et al.  (1984), fol-
lowed by Resnick et al. (1986), Kondo et al. (1990), Warburg et al. (1990) and Özturk
34
35
Figure 9.
Fundus changes of the youngest Cohen syndrome patients.
C. An 8-year-old boy with a pale,
atrophic disk and narrow vessels. Ex-
tremely atrophic retina, RPE and
choroid. A definite bull’s-eye macula,
fine pigment granularity in the midpe-
riphery.
A. A 5-year-old girl with a normal disk,
normal appearing retina and retinal pig-
ment epithelium (RPE), but fine pig-
ment granularity outside the macula
seen inferior to the temporal arcade.
B. A 7-year-old girl with a pale disk,
narrow vessels and pale atrophic fun-
dus. A central island of thicker retina
and retinal RPE, a bull’s-eye macula
and small pigment granules outside the
temporal arcades.
D. A 14-year-old boy with a pale disk,
peripapillary atrophy, narrow vessels,
atrophic and pale fundus and choroidal
vessels seen especially in the macular
area and inferior to the disk.
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Figure 10.
Progression of fundus changes in a young adult with Cohen syndrome.
A. A 22-year-old male patient.
D. The optic disk is pale and more
atrophic, and peripapillary atrophy has
advanced. Bone spiculae pigmentation
has approached the posterior pole and
the central area of thicker retina has di-
minished in size.
C. The same patient 12 years later.
B. His fundus: the optic disk is pale and
atrophic, the vessels, especially arteri-
oles, are narrow, retina and RPE sur-
rounding the posterior pole are atroph-
ic. Small pigment clumps are present
peripapillary and outside the arcades.
There is a central island of thicker reti-
na and bull’s-eye macula.
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Figure 11.
Progression of fundus changes.
A. A 27-year- old  female patient,
sister of the patient in 10.
D. Peripapillar atrophy has advanced,
stellate atrophy surrounds the
pigmentated macula and the number
of bone spiculae pigmentation has
increased markedly.
C. The same female patient 12 years later.
B. Her fundus: the optic disk is pale
and vessels, especially arterioles,
are narrow, marked
retinochoroidal atrophy is present
with bone spiculae pigmentation
and a bull’s-eye macula.
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B. More advanced changes in the same eye 10 years later:
vessels are hardly visible, and peripapillary atrophy, as
well as areolar retinochoroidal atrophy towards the macula
have increased. The number of pigment clumps has also
increased. Visual acuity had decreased from counting
fingers at 5 meters to mere light perception.
Figure 12.
Progression of fundus changes in a middle-aged Cohen syndrome patient.
A. Fundus of a 47-year-old male patient shows an
extremely pale and atrophic disk with peripapillary
atrophy and extremely narrow vessels. Marked
retinochoroidal atrophy approaching the macula in an
areolar shape, and pigment clumps and bone spiculae
up to the disk. A bull’s-eye macula.
and Weber. (1991). Signs of retinochoroidal dystrophy varied at different ages. Flash-
evoked ERG using lid electrodes was normal in the two youngest patients aged 2 and 5
years. However, the possibility of early rod dysfunction cannot be ruled out with the
non-corneal ERG method we used. All others had isoelectric ERG. In the youngest
patient with markedly impaired visual function by 15 years of age, the ERG had been
isoelectric since the age of 4 years. The progression of retinochoroidal dystrophy is slow
but inevitable.
As judged from the abnormalities in ERG recordings in our patients and in the literature
(Balestrazzi et al, 1980, Norio et al, 1984, North et al, 1985, Resnick et al, 1986, Steinlein
et  al, 1992, North et al, 1995, Fryns et al, 1996), the neuroectodermally derived structures,
viz. the retina and RPE, appear to be primarily affected.  This neuroectodermal  expression
is progressive, unlike the affection on central nervous system, which causes mental retar-
dation. As long as the basic mechanism responsible for these changes remains unknown,
the prevention of progressive retinochoroidal changes is not possible.
4. Haematological studies (IV)
Peripheral blood cell counts had been measured at least once in all the 29 patients.
Subnormal values of neutrophil granulocytes were noted in every patient (Fig 13, Table
7). Neutropenia was present at all ages, in one patient already at the age of 2 days (0.56
x 109/l).  Neutropenia was usually mild or moderate and its level fluctuated in the sub-
normal range with occasional normal values, but it was not cyclic. At least some of the
patients have responded to bacterial infections with neutrophilic leucocytosis, as exem-
plified by a 2-year-old boy whose neutrophils rose from 0.54 to 11.82 x109/l during a
case of pneumococcal septicaemia. In general, patients were not prone to severe infec-
tions.
All but 2 of the 16 restudied patients had isolated granulocytopenia (0.53-1.36, median
0.83 x 109/l) at the time of cross-sectional evaluation. These patients were not anaemic
and their platelet counts were normal. Reticulocyte percentages varied from 1.8 to 4.0.
Nobody had significant eosinophilia or monocytosis. There were no blasts in the periph-
eral blood. The size of the spleen was normal. The overall cellularity of the bone marrow
was normal or increased. The marrow showed no qualitative changes. In 8 patients,
however, a left-shifted granulopoiesis was noted (Table 8). The colony growths of CFU-
GM were within normal limits. Adrenaline injection failed to double the neutrophil
count in 5-15 minutes in 11/14 patients and in 60-240 minutes in 3/14 patients (Fig. 14).
Hydrocortisone injection failed to raise the neutrophil count >2.0 x 109/l in 8/16 pa-
tients (Fig. 15). The rhG-CSF provoked neutrophil increase in the 3 patients studied
up to 4.2, 7.4 and 8.9 x 109/l, respectively (Fig. 16).
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Table 7. Mean values and ranges of blood pictures of  29 Cohen patients.
Table 8. Numbers of marrow myeloid cells (medians and ranges) per 200  polychro-
matic erythroblasts in 16 Cohen patients and in 16 age- and sex-matched controls.
Neutrophils
Promyelocytes Myelocytes Metamyelocytes Bands Segmented
Patients 45 108 151 95 101
(17-85) (56-178) (81-230) (61-178) (52-284)
Controls 26 90 118 94 125
(13-44) (62-138) (80-158) (48-129) (71-173)
p 0.006 0.141 0.073 0.720 0.020
Range
100-158
1.0-4.0
2.0-11.0
0.220-1.029
0-8
2-42
0-7
0-5
0-15
50-97
203-465
Haemoglobin g/l
Reticulocytes %
Leucocytes 109/l
ANC 109/l
Neutrophiles/bands %
Neutrophiles/segmented %
Eosinophiles %
Basophiles %
Monocytes %
Lymphocytes %
Trombocytes  109/l
Mean
131
        2.5  (n=16)
4.3
0.883
1.8
18.5
2.4
0.6
2.9
71.1
       286  (n=24)
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Isolated neutrophilic granulocytopenia was observed in all Finnish patients, showing
that neutropenia is an essential feature of the syndrome. As only anecdotal neutropen-
ic Cohen patients have been described elsewhere, a genetic heterogeneity has been
suggested within the syndrome (Warburg et al, 1990). However, we found that neutro-
penia is intermittent and often associated with normal total white blood cell count in
the peripheral blood. Neutropenia might therefore well exist but remain unnoticed
also in other Cohen patients. The granulocytopenia was present from early age, even
from birth, as also described by Fryns et al.(1996). It is not progressive and seems not
to be associated with a malignant development. Other blood cell lineages remain un-
affected. The proportions of eosinophiles and monocytes are usually not elevated, in
contrast to those in patients with chronic or autoimmune granulocytopenia (Pincus et
al, 1976, Shastri and Logue, 1993). No qualitative abnormalities or cytogenetic changes
were found in the blood cells.  Although the basic mechanism remains unsolved, the
neutropenia may be due to impaired myeloid maturation that can be corrected by rhG-
CSF. The spectrum and severity of infections in our patients resemble those seen in
patients with chronic benign granulocytopenia (Rajantie et  al, 1993) and not those
seen in patients with granulocytopenia due to bone marrow aplasia (Kostmann 1975).
This is in accordance with the view of only partial impairment of neutrophil produc-
tion. Therefore, the clinical use of granulocyte growth factors should be reserved only
for use in the unlikely cases with life-threatening or repeated severe infections. How-
ever, patients had increased susceptibility to early periodontal breakdown, which is
likely to be associated with granulocytopenia (Alaluusua et  al, 1997).
As patients with Cohen syndrome have periods of isolated neutrophilic granulocyto-
penia, leucocyte counts and differentials should be investigated in all suspected Co-
hen patients. The presence of granulocytopenia may confirm the diagnosis in young
patients who have not yet developed typical facial appearance and ophthalmologic
changes. It has even been suggested (Fryns et al, 1996) that screening for leucopenia
and neutropenia should be a routine procedure in young children with manifest delay
in psychomotor development and rest hypotonia in order to detect patients with Co-
hen syndrome. On the other hand, extensive haematological investigations or follow-
up, however, are usually not warranted in patients with Cohen syndrome.
5. Other results (V)
Cardiac examinations
Detailed cardiac examinations of 20 patients revealed grade 1 - 3 systolic murmur in
6. In addition, from the 9 patients one had a systolic murmur. Diastolic blood pressure
was elevated (more than 90 mmHg) in 4 patients out of 20. Enlarged heart volume of
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more than 450 cc/m2  was found in 2 female patients, both 39 years old. Normal ECGs
were found in 13 patients. In 7 patients there were ST-segment abnormalities (ST-
segment depression, T-wave inversion) in leads II, III, AVF or left pericardial leads.
The ultrasound examination failed for 2 patients, a 44-year-old male and a 57- year-
old male because of technical problems due to kyphoscoliosis. The intracardial and
vessel anatomy was normal in all the other 18 patients examined. However, the left
ventricular ejection fraction decreased progressively with advancing age (R=0.69,
p=0.015) and was less than 0.50 in 3 patients at the ages of 27, 45 and 47. In addition,
left ventricular end systolic diameter  and left ventricular end diastolic diameter  in-
creased with advancing age (p=0.04, r=0.49, and p=0.09, r=0,41). There were no ab-
normal findings in aortic diameter, septum diameter or posterior wall diameter.
Floppy mitral valve with mild prolapse, but no regurgitation, was detected in 2 pa-
tients: a male patient aged 32 years with normal left ventricular function and a female
patient aged 45 years with decreased left ventricular function. Haemodynamically
insignificant aortic regurgitation without prolapse was found in 9 patients. No patient
had significant tricuspid or pulmonary valve regurgitation.
Although 24% of patients had had systolic murmurs, echo studies revealed no abnor-
malities in the cardiac anatomy of 18 studied patients. Cohen syndrome has been sug-
gested to be a connective tissue disorder because of reports of mitral prolapses (Mehes
et al, 1988). In the present study, a floppy mitral valve without regurgitation was found
in only two of the 18 patients examined. The aortic root diameter in diastole was more
than 2 SD in three patients and within normal limits in all the others. Thus the hypothe-
sis of a connective tissue disorder was not reinforced from this point of view.
A remarkable new finding was the decreased left ventricular function with advancing
age detected by echocardiography. ST-segment abnormalities in the patients’ ECGs
support this finding. Women over 40 years of age in particular were affected. De-
creased left ventricular function might be caused by early myocardial degeneration,
but further studies should be done.
Evaluation of endocrine function
The height of two out of 7 children aged 11 months to 14 years was significantly short
as judged by Finnish standards (height standard deviation score (SDS) below –2.0).
Other children were not significantly short. The height of a 15-year-old girl, late in
onset of puberty, was –4.2 SDS. The height of 13 out of of 21 adult patients was
normal, SDS between 0 and –2.0. In 8 adults height SDS was below –2.0. All but one
of these patients had severe kyphosis. The chest radiographs taken of four of them
showed kyphosis angles of 36°, 55°, 72° and 86°.
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Unfortunately, previous height measurements of our older patients were too scanty
and inconsistent to permit proper statistical evaluation of growth. Height varied con-
siderably, between –1 and –4.4 SD.
One of the children was obese with weight for height at 5 years of age +30%. Weight
for height was normal in the other six children. Three adult patients were obese, with
BMIs of 31, 32 and 36. Two of them had always been obese, and for the third we had
no previous weight measurements. Four patients were very thin, with BMIs below 20.
Of them three had never been obese and for one we had no previous weight measure-
ments. The remaining 14 adults had BMIs between 20 and 30, which is considered
normal. Of these ten patients, one patient with BMI 29 had had 0% of weight for
height until the age of 7 years, after which he gained weight up to +20% and +30% at
the ages of 8 and 12, respectively. Five of them had never been obese, and for the four
oldest patients we had no previous weight measurements. When present, the obesity
was mostly truncal.
Mean age at menarche was 15.4 years, range 13 - 17 years. In the males, some signs of
puberty were observed between the ages of 15 and 20 years. All the adults had com-
plete secondary sexual development.
Thyroid function (plasma levels of free thyroxin and TSH) was normal in all the 18
patients studied. In gonadal function we found no abnormalities. All adult patients
had normal basal plasma levels of LH and FSH. Two prepubertal patients were stud-
ied and had normal basal and GNRH-stimulated LH and FSH levels. Estrogen levels
were normal in both of the prepubertal girls and in a 20-year-old female with regular
menstruation not receiving lynesterol medication. Testosterone levels were normal in
all the prepubertal males. Adult males had low normal testosterone levels from 8.0
nmol/l to 13 nmol/l  (lower limit in normal adult men 11.0 nmol/l).
Anterior pituitary and adrenocortical functions were normal. Plasma growth hormone
response to insulin induced hypoglycemia and arginin infusion was normal (5.5 - 12.9
ug/l) in four and low normal (4.3 ug/l) in one patient. Plasma insulin-like growth
factor (IGF-1) levels were normal. So were the potassium and sodium levels.
One patient had type II diabetes controlled by diet. Fasting glucose and blood HbA1C
concentrations were normal in all the others.
In many previous studies, patients with Cohen syndrome have been reported to be
short (Cohen et al, 1973, Carey and Hall, 1978, Kousseff 1981, de Toni and Cafiero,
1982, Goecke et al, 1982, Resnick et al, 1986, Young and Moore, 1987, Zeller et al,
1987, Warburg et al, 1990, North et al, 1995). Of our patients, 11 out of 29 were below
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-2SDS. In addition they often had significant thoracic kyphosis which had reduced
their height. Also muscular hypotonia may reduce height.
Obesity was not very common in our series, contrary to earlier reports (Balestrazzi et
al, 1980, Kousseff 1981, de Toni and Cafiero, 1982, Goecke et al, 1982, Sack and
Friedman, 1986, North et al, 1995).
Pubertal development was often delayed in our series, as in others (Fryns et al, 1981,
Kousseff 1981, Sack and Friedman, 1986, Kondo et al, 1990, Warburg et al, 1990, North
et al, 1995), but both males and females acquired adult sexual characters. No abnormali-
ties of the pituitary-gonadal axis were found. Delayed puberty is probably a nonspecific
finding, common to many other patients with mental retardation (Huovinen 1993).
Skeletal features
The chest X-rays showed normal hearts and lungs. Out of 16 patients, 12 had thoracic
kyphosis (more than 40°). Kyphosis was mild (angle between 40 to 65°) in 7 patients,
moderate (angle between 65-85°) in 4 patients and severe (angle over 85°) in one
patient. Out of 17 patients 10 had scoliosis of more than 10°, but only two had angles
of 30° or more. Out of 16 patients 15 had different grades of calcaneovalgus position
in ankle X-rays taken in the standing position. Kyphosis and pes calcaneovalgus have
often been reported to be features of Cohen syndrome (Cohen et al, 1973, Kousseff
1981, Friedman and Sack, 1982, Norio et al, 1984, Nambu et al, 1988, Warburg et al,
1990, Özturk and Weber, 1991). In our series they were also common. They may be
consequences of hypotonia, and appropriate treatment for standard indications should
be given. Judging from the X-rays, the long bones are often thin, but the bony struc-
ture is normal and shows no abnormal calcification.
All Cohen patients had very high relative slenderness of their measured hand bones.
This means that their fingers were long in relation to their thickness. The pattern pro-
file measurements (10 females and 9 males) of all metacarpal bones were under 0 SD.
The metacarpophalangeal pattern profile was characteristic (Fig 17). All measured
bones of hands were short, the medial and especially the distal phalanges were short-
est and the proximal phalanges were relatively longest. The marked relative slender-
ness may give the impression of long fingers, but actually Cohen patients have short
but slender fingers, and not long and slender as mentioned in many reports (Kousseff
1981, Norio et al, 1984, Kondo et al, 1990). Their hands and feet are small and narrow
in agreement with earlier reports  (Cohen et al, 1973, Carey and Hall, 1978, Kousseff
1981, Norio et al, 1984, Kondo et al, 1990).
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Figure 17.
The metacarpophalangeal pattern profile of Cohen patients. All the bones of the hand
are short, but the relatively shortest bones are the medial and distal phalanges, espe-
cially distal phalanx IV.
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GENERAL DISCUSSION
1. Diagnostic criteria for the “Finnish” Cohen syndrome
The mode of collecting this patients series was planned so that the series would be as
homogenous as possible. This also means that atypical and borderline cases were
omitted. When these cases were encountered, they possibly showed several symp-
toms and signs of the syndrome, but the general impression was inadequate or some
essential features were lacking, such as ophthalmologic findings. Such patients were
called “cohenoid”. However, in most cases it was not difficult to draw the line be-
tween real Cohen patients and cohenoids. Whether some of the omitted cases, never-
theless, were caused by the same gene, remains to be decided in further studies and, in
particular, after that gene diagnosis is available.
All our patients had the following features, which are considered  to be essential fea-
tures in Cohen syndrome:
- Non-progressive psychomotor retardation, motor clumsiness and microcephaly.
- Typical facial features: High-arched or wave-shaped eyelids, short philtrum, thick
hair and low hairline.
- Childhood hypotonia and hyperextensibility of the joints.
- Ophthalmologic findings of retinochoroidal dystrophy and myopia in patients over
5 years of age.
- Periods of isolated granulocytopenia.
The following findings strongly support the diagnosis:
- long or thick eyelashes, thick eyebrows, prominent root of nose, prominent upper
central incisors, high or narrow palate
- relatively enlarged corpus callosum in brain MRI
- low-voltage EEG in patients over 14 years of age
- typical metacarpophalangeal pattern profile
- slender and short fingers
- a wide gap between toes 1 and 2
- early lens opacities
- almost total absence of maladaptive behaviour, viz. ”cheerful disposition”
The following features are often seen:
- delayed puberty
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- short stature
- scoliosis
- kyphosis
- pes calcaneovalgus
- cubitus valgus
- mild syndactylies
- antimongoloid slant of eyelids
- small or absent lobuli of ears
The percentages are shown in Table 5.
2. Suggestions for diagnostic procedures
The suspicion of Cohen syndrome arises with patients who are microcephalic, men-
tally retarded and have typical facial features. After that an ophthalmologist should be
consulted and ANC (absolute neutrophil count) should be investigated. If the patient
has microcephaly, mental retardation and developmental delay, signs of chorioretinal
dystrophy, myopia and granulocytopenia, no differential diagnostic problems exist,
because no other syndrome has this specific combination (Oxford Medical Databas-
es). However, MRI of the brain is important especially in young children who may not
yet have ophthalmologic changes. Relatively enlarged CC supports the diagnosis and
on the other hand MRI excludes many other possible causes of mental retardation.
If investigations have not been made to detect all of the essential features, differential
diagnostic problems exist. If patient has mental retardation, retinitis pigmentosa and
microcephaly, there are about 30 syndromes possible, if patient has mental retarda-
tion, retinitis pigmentosa and myopia there are 14 possible syndromes (Oxford Med-
ical Databases).
3. Natural history
Cohen syndrome manifests very differently at different ages. The diagnosis is really
difficult in infants. It is easiest at school age. In time the facial features lose their most
typical characteristics, while the ophthalmologic findings become more and more ap-
parent.
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Figure 18. The youngest pa-
tient diagnosed to have Cohen
syndrome. An 11-month-old
boy.
Pregnancy, delivery and neonatal period
Pregnancy and delivery are usually normal, though
foetal movements can be diminished. As newborns
the babies are considered normal. The characteris-
tic facial features can not be seen at this age. The
head circumference is with in normal limits. Gran-
ulocytopenia can be  present from birth.
Infancy  (0-1 years)
Neonatal feeding problems are common. Babies
are often hypotonic already during the first months
of life. Finally from 6 to 12 months of age it be-
comes obvious that development is not normal and
children are brought to a doctor. At that time they
have hypotonia, microcephaly and delayed devel-
opmental milestones. Most have good, sociable
contact from the beginning and show no signs of autism. No signs of cerebral palsy
are seen. Use of sight is normal at this age and babies hear normally. At this age
characteristic facial features are difficult to recognize. However, the youngest ever
diagnosed patient is 11 months old (Fig 18). Afterwards many parents remember to
have been worried about their children from a very early age, especially if they had
experienced healthy babies before.
Pre-school age (2-6 years)
In this period psychomotor retardation is obvious. Many children receive physical
therapy for motor delay. All patients learn to walk by the age of 2 to 5 years. Speech
development is delayed, but all learn to speak at some level, which varies a lot even
among siblings. At this age speech therapy is important. Already at this age some
patients have myopia, and sometimes the earliest fundus changes, viz. pale disc and
generally pale fundus with or without pigment granularity, can be seen. Some have
difficulties to see in the dusk. However, most have no ophthalmologic symptoms
and findings at this age. Because of the obvious developmental delay many causes
of mental retardation are usually excluded by various tests. EEG is normal. No signs
of muscle diseases are found. Brain MRI is considered normal, though corpus callo-
sum is relatively enlarged. Many Cohen children have recurrent upper respiratory
infections at this time. Whether this is a result of granulocytopenia or floppiness
and retardation can not be judged. However, patients have no fatal infections, and
granulocytes seem to rise normally in cases of severe bacterial infections. Typical
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Figure 19. Cohen patients at infancy and pre-school age.
D. Children at our first course for Cohen families.
A. A 2-year-old boy B. A 3-year-old boy C. A 4-year-old girl.
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facial features become more and more characteristic by 5 years of age (Fig. 19).
Cohen children at this age are generally considered as very beautiful children.
School age (7-14)
Patients are not able to attend normal school, thus all attend special schools. Mental
retardation does not progress and patients learn new things.  Facial features are evi-
dent (Fig 20), and very often the diagnosis is made at this age. At this period myopia
is always present and signs of retinochoroidal dystrophy are usually found. Patients
receive glasses and like to wear them. Because of severe pes calcaneovalgus some
patients need orthopaedic intervention.
Figure 20. Cohen patients at school age
A. A 6-year-old girl B. A 7-year-old boy
C. A 14-year-old girl. D. A 15-year-old boy
Note short filtrum
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Pubertal age (15-19 years)
Puberty is often delayed. No endocrine abnormalities are found. Patients are often
short but after pubertal growth reach short normal (median –2 SD) height. Low-
voltage non-irritative EEG is found from this age on. Myopia has often progressed to
malignant level (>-6 Diopters). Moderate fundus changes, narrow vessels and pigment
clumps and bone-spiculae-like pigment accumulations appear and patients suffer from
nyctalopia and narrowed visual fields. Even teenagers may have peripheral lens
opacities.
Adulthood (20-40 years)
Facial features remain recognisable for decades (Fig. 21 A,B,C), however they show
signs of premature ageing. Vision deteriorates slowly, but remains relatively good in
most patients until the age of 30 years. Already young adults have early nuclear scle-
rosis.
Figure 21. Adult Cohen patients
A. A 20-year-old male B. A 26-year old female C. A 39-year-old female
D.
Three
siblings aged
45, 39 and
32 years.
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Middle age (40-60 years)
The facial features tend to lose their most characteristic appearance (Fig 22 D). Pa-
tients are usually in good somatic health. However, decreased left ventricular function
with advancing age may be found. Ophthalmologic changes progress at this age: the
number and size of pigment deposits increases and approaches the posterior pole by
35 to 40 years of age. Patients over 45 years of age have severe retinochoroidal atro-
phy. A bull’s eye macula is seen in most patients. Most have posterior subcapsular
cataract. Iris atrophies and shallow anterior chambers possibly leading to angle clo-
sure glaucoma may be seen. However, ophthalmologic abnormalities, though pro-
gressive, do not lead to total blindness.
Old age 60 -  years
At present, data on this age group are still lacking. The life span does not seem to be
shortened.
4. Heterogeneity of the syndrome
Altogether over one hundred patients have been published to have Cohen syndrome.
In table 9 112 previously published  Cohen patients are evaluated according to the
features we consider essential for the syndrome. Out of these patients reported abroad
20 (Cohen et al, 1973, Carey and Hall, 1978, Ferre et al, 1982, Resnick et al, 1986,
Warburg et al, 1990, Kondo et al, 1990, Özturk and Weber, 1991, Steinlein et al, 1991,
Fryns et al, 1996) show the same clinical symptoms as our patients. Furthermore four
patients published as having Mirhosseini-Holmes-Walton syndrome (Mirhosseini et
al, 1972, Mendez et  al, 1985) are similar to our patients. Thus the “Finnish” Cohen
syndrome is not solely a Finnish speciality.
The original patients published by Cohen et al. (1973) most probably were similar to
the Finnish ones. The expression “mottled retina” probably represents chorioretinal
dystrophy. The full certainty cannot be achieved, because these patients have been
lost from the follow-up (Cohen, personal communication).
Ophthalmologic features are important in Cohen syndrome. Patients claimed to have
Cohen syndrome without the typical ophthalmologic features may not have the same
syndrome as our patients or the ophthalmologic investigation has not been appropri-
ate enough. The further molecular genetic studies will solve whether patients showing
features different from the Finnish patients have a disease caused by another gene or
different mutations of the gene localized to the long arm of chromosome 8.
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Table 9. Essential features in published patients claimed to have Cohen syndrome.
Article Age/
Sex
Mental
retarda-
tion
Micro-
cephaly
Typical habitus Ophthalmologic findings Granulo-
cytopenia
Diagnosis
Compa-
tible with
Finnish
criteria
(+, ?, -)
Facial Other Myopia Mottled
retina,
chorioretinal
dystophy or
ERG
abnormality
Balestrazzi
1980
11/M - + - - + - - ND
10/M ? + - No picture + + + ND
Carey 1978 11/M + - - + + - + ND
5/M + + - - + + - ND
15/M + + + + + + - ND
14/F + + + + + - - ND
Cohen 1973 18/F + + + + + + + ND
15/M + + + + + + + ND
8/F + + - + + - - ND
Doyard 1984 7/F - + - - + - - ND
6/M - + - - + - - ND
Ferre 1982 6/F + + + + + + - ND
9/F + + + + + + - ND
Friedman
1982
12/F ? + - ? + + + ND
7/M - + - - - - - ND
13/M - + - - - - - ND
10/F - + - - - - - ND
16/F ? + - + + + - ND
Fryns 81 9/M - + + - + - - ND
Fryns 90 15/F - + + - + + - ND
Fryns 96 6/F + + + + + + + +
6/F + + + + + + + +
3/F + + + + + + + +
1/F + + + + + + + +
Fuhrmann
1984
12/F - + - - - - - ND
Goecke 1982 11/F - + - - + - - ND
10/F - + + - + - - ND
13/F - + - - + - - ND
Higgins 1994 4/F - + - - + - - ND
Kondo 1990 21/M + + + + + + + +
15/M + + + + + + + +
Koussef 1981 15/M - + + - + - - ND
18/M - + + - + - - ND
17/F - + + - + - - ND
12/F - + + ? + - - ND
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Article Age/
Sex
Mental
retarda-
tion
Micro-
cephaly
Typical habitus Ophthalmologic findings Granulo-
cytopenia
Diagnosis
Compa-
tible with
Finnish
criteria
(+, ?, -)
Facial Other Myopia Mottled
retina,
chorioretinal
dystophy or
ERG
abnormality
Martinez 1991 - + - ? + + - no
- + - ? + + - no
Massa 1991 12/F - + - - - - - ND
28/M + + + + + ND + NDMirhosseini
1972 (not
published as
Cohen syndrome)
24/M + + + + + ND + ND
Mehes 1988 2/F - + + - + - - ND
18/F + + + + + + + NDMendes 1985
(not published as
Cohen syndrome) 9/F + + + + + ND + ND
Moreno-
Montanes
1988
18 - + ND No
Picture
ND + - ND
Nambu 1988 12/F - + - - + - - ND
North C 1985 15/M - + - - + + + No
16/M - + - - + - - No
10/F - + - - + - + No
1/M - + - - + - + No
8/M - + - - + - - No
4/F - + - - + - - No
North K 1995 8/F ? + - ? - + + ND
8/F ? + - ? - + + ND
Okamoto 1998 15/F ? + + No picture + + + +
3/F ? + + No picture + + + +
9/F ? + ? No picture ? + ? ?
Resnick 1985 17/F + + + + + + + ND
Rizzo1987 10/F - + - - - - No
Sack 1980 12/F ? + - ? + + + ND
Sack 1986 n:o 39 ? + - ? + - - ND
Schlictemeier
1994
13/M - + + - + ND ND ND
17/F - + + - + ND ND ND
Steinlein 1991 30/M + + - + + Nd + +
28/M + + + + + Nd + +
deToni 1982 16/F - + - - + + - ND
Warburg
1989
27/F + + + + + + + +
Wilson 1985 10/F - + - - - - - ND
Young 1987 15/M - + - - + - - ND
13/F - + - ? + - - ND
10/F - + + ? + - + ND
Zeller 1987 18/M - + - - - - - ND
Zetler  1987 11/M - + + - + - - ND
7/M - + - - + - - ND
Özturk 14/F + + + + + + + +
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5.   Clinical consequences of the Cohen syndrome diagnosis
An exact etiological diagnosis is important for every mentally retarded individual.
The diagnosis of Cohen syndrome denotes that the retardation is not progressive. The
exceptionally positive psychic character makes daily life easier than in most other
diseases with mental retardation. The majority of patients may live at home instead in
an institution. The ophthalmologic features demand adequate glass correction, bright
lighting, safe routes at home and outdoors - and insight on the existence of visual
problems. Granulocytopenia does not demand extensive haematological investiga-
tions nor does it make the patient predisposed to severe infections. Genetic counsel-
ling can already now be based on recessive inheritance and will soon - as we hope -
benefit from molecular genetic diagnosis.
56
CONCLUSIONS AND SUMMARY
The present study elucidates the clinical picture in Cohen syndrome (MIM n:o 216550),
which is an autosomal recessive disorder affecting many organs. Because specific diag-
nostic tools are lacking, diagnosis is based on the typical clinical picture: psychomotor
retardation, microcephalia, hypotonia, typical craniofacial features, granulocytopenia
and ophthalmologic abnormalities. In this nationwide study of this rare disease over-
represented in Finland, examinations were performed on 29 Cohen patients, who
form a highly homogenous group aged from 11 months to 57 years.
1. Cohen syndrome should be suspected in children who after normal birth by the age
of 6 months to one year show hypotonia, microcephalia, delayed developmental
milestones and non-progressive psychomotor retardation in addition to typical
facial features.
2. Magnetic resonance images of the brain with quantitative analyses of internal
skull surface, brain stem and corpus callosum revealed a relatively enlarged corpus
callosum. Such a finding has not previously been reported to be associated with
mental retardation.
3.  None of the patients had epilepsy. In EEG studies the three youngest patients
(aged 11 months, 3 and 5 years) had normal EEGs, while all others had lowvoltage
EEGs. No irritative spikes or epileptiformic foci were found. Nine patients had
quick beta transients.
4. In psychological tests 22 % of patients were profoundly, 61 % severely, 6 %
moderately and 11% mildly retarded. In an adaptive behaviour scale for children
and adults (AAMD) Cohen patients had high scores in the positive domains, viz.
selfdirection, responsibility and socialisation, while maladaptive behaviour was
almost lacking. These findings are in agreement with the cheerful and sociable
disposition reported to belong to Cohen syndrome.
5. In ophthalmologic studies only the youngest patients under the age of 5 years
had unimpaired visual function. Vision started to deteriorate early, but remained
relatively good in most patients until the age of 30. After the age of 40 many
patients were severely visually handicapped, but none was totally blind. Progres-
sive, often high-grade, myopia and progressive retinochoroidal dystrophy resemb-
ling retinitis pigmentosa are considered to be essential features in Cohen synd-
rome. Thus, the diagnosis of this syndrome can not be made without them, except
in the youngest patients under 5 years of age. Other typical findings are strabismus,
early lens opacities, shallow anterior chamber and iris atrophy.
6. In haematological studies all patients had periods of granulocytopenia, which
was mild to moderate, non-cyclic and never fatal. It may be due to impaired
myeloid maturation. No bone marrow malignancies were seen. However, patients
had increased susceptibility to early periodontal breakdown, which might be
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associated with granulocytopenia. Use of granulocyte growth factors corrects the
neutropenia but their use may be indicated only for  severe or life-threatening
infections.
7. In cardiac studies the heart anatomy was normal and no tendency for clinically
significant mitral prolapse was found. However,  decreased left ventricular
function with advancing age was found.
8. In endocrine studies no significant abnormalities were found. However,
puberty was delayed. Obesity and significantly short stature were not essential
features.
9. Other radiological studies confirmed kyphosis, scoliosis and calcaneo plano
valgus to be common features in Cohen syndrome, but most probably secondary
to marked hypotonia. Fingers were slender but short. The patients had a metacar
pophalangeal pattern profile that differs from normal population.
10. Heterogeneity seems to exist among reported Cohen patients. The further
molecular studies will solve whether patients showing features different from the
Finnish patients have a disease caused by another gene or different mutations of
the same gene.
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